Jeito Capital — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
NMD Pharmanmdpharma.comin𝕏Nov 2023 · $81.3M✓ verified
NMD Pharma is a clinical-stage biotech company developing first-in-class small-molecule therapies that selectively target skeletal muscle to treat rare neuromuscular diseases and age-related conditions.
BiotechDeep TechHealthtechMedical DevicesAarhus, DK
Co-investorsNovo HoldingsRoche Venture FundInkef
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.